Inhibitory Effects of Terminalia chebula Extract on Glycation and Endothelial Cell Adhesion

Abstract

Terminalia chebula Retz. has been used in India for a long time to treat many diseases, and its extract was reported to have antidiabetic activity in vivo. In this study, T. chebula methanolic extract (TCE) containing 2.7 % chebulic acid was evaluated for its preventive effects against the formation of advanced glycation end products (AGEs) and endothelial cell dysfuction. When the effects of TCE on AGE formation and on protein crossing-linking by glycation with D-threose and lens crystallines were examined, TCE showed inhibitory activity in a dose-dependent manner, and the concentration of 1000 µg/mL presented an activity similar to that of 5 mM aminoguanidine as a positive control. Upon investigating the protective activity of TCE against AGE-induced vascular endothelium dysfunction, human umbilical vein endothelial cells (HUVEC) incubated with 100 µg/mL of AGEs had significantly enhanced reactive oxygen species (ROS) formation, whereas the treatment of T. chebula reduced AGE-induced ROS generation. The incubation of HUVEC with 100 µg/mL of AGEs caused a considerable increase in THP-1 monocytic cell adhesion, but this adhesion was reduced by the treatment of TCE. These results suggest that TCE is a potential agent for alleviating diabetic complications.

Key words

Terminalia chebula Retz. - Combretaceae - advanced glycation end products - diabetic complications - antioxidant - lens crystalline

References

• 1 Morello C M. Etiology and natural history of diabetic retinopathy: an overview.  Am J Health Syst Pharm. 2007;  64 S3-S7
• 2 Brownlee M. Biochemistry and molecular cell biology of diabetic complications.  Nature. 2001;  414 813-820
• 3 Reddy V P, Beyaz A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases.  Drug Discov Today. 2006;  11 646-654
• 4 Lingelbach L B, Mitchell A E, Rucker R B, McDonald R B. Accumulation of advanced glycation endproducts in aging male Fischer 344 rats during long-term feeding of various dietary carbohydrates.  J Nutr. 2000;  130 1247-1255
• 5 Deelman L, Sharma K. Mechanisms of kidney fibrosis and the role of antifibrotic therapies.  Curr Opin Nephrol Hypertens. 2009;  18 85-90
• 6 Rao N, Nammi S. Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats.  BMC Complement Altern Med. 2006;  6 17-22
• 7 Ishtiaq M, Hanif W, Khan M A, Ashraf M, Butt A M. An ethnomedicinal survey and documentation of important medicinal folklore food phytonims of flora of Samahni valley, (Azad Kashmir) Pakistan.  Pakistan J Biol Sci. 2007;  10 2241-2256
• 8 Dutta B K, Rahman I, Das T K. Antifungal activity of Indian plant extracts: Antimyzetische Aktivität indischer Pflanzenextrakte.  Mycoses. 1998;  41 535-536
• 9 Malekzadeh F, Ehsanifar H, Shahamat M, Levin M, Colwell R R. Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori.  Int J Antimicrob Agents. 2001;  18 85-88
• 10 Prasad L, Khan T H, Jahangir T, Sultana S. Abrogation of DEN/Fe-NTA induced carcinogenic response, oxidative damage and subsequent cell proliferation response by Terminalia chebula in kidney of Wistar rats.  Pharmazie. 2007;  62 790-797
• 11 Senthilkumar G P, Subramanian S P. Biochemical studies on the effect of Terminalia chebula on the levels of glycoproteins in streptozotocin-induced experimental diabetes in rats.  J Appl Biomed. 2006;  6 17
• 12 Murali Y K, Anand P, Tandon V, Singh R, Chandra R, Murthy P S. Long-term effects of Terminalia chebula Retz. on hyperglycemia and associated hyperlipidemia, tissue glycogen content and in vitro release of insulin in streptozotocin induced diabetic rats.  Exp Clin Endocrinol Diabetes. 2007;  115 641-646
• 13 Lee H S, Jung S H, Yun B S, Lee K W. Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes.  Arch Toxicol. 2007;  81 211-218
• 14 Ahn M J, Kim C Y, Lee J S, Kim T G, Kim S H, Lee C K, Lee B B, Shin C G, Huh H, Kim J. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis.  Planta Med. 2002;  68 457-459
• 15 Lee H S, Nam H W, Kyoung H K, Lee H, Jun W, Lee K W. Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro.  Biol Pharm Bull. 2005;  28 1639-1644
• 16 Choi S Y, Jung S H, Lee H S, Park K W, Yun B S, Lee K W. Glycation inhibitory activity and the identification of an active compound in Plantago asiatica extract.  Phytother Res. 2008;  22 323-329
• 17 Ghiselli A, Serafini M, Maiani G, Azzini E, Ferro-Luzzi A. A fluorescence-based method for measuring total plasma antioxidant capability.  Free Radic Biol Med. 1995;  18 29-36
• 18 Yildiz G, Demiryürek A T, Sahin-Erdemli I, Kanzik I. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence.  Br J Pharmacol. 1998;  124 905-910
• 19 Courderot-Masuyer C, Dalloz F, Maupoil V, Rochette L. Antioxidant properties of aminoguanidine.  Fundam Clin Pharmacol. 1999;  13 535-540
• 20 Thornalley P J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts.  Arch Biochem Biophys. 2003;  419 31-40
• 21 Tyagi N, Ovechkin A V, Lominadze D, Moshal K S, Tyagi S C. Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia.  J Cell Biochem. 2006;  98 1150-1162
• 22 Hiraoka M, Nitta N, Nagai M, Shimokado K, Yoshida M. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.  Life Sci. 2004;  75 1333-1341
• 23 Bustos P, Duffau C, Pacheco C, Ulloa N. [beta]-Sitosterol modulation of monocyte-endothelial cell interaction: a comparison to female hormones.  Maturitas. 2008;  60 202-208
• 24 Lee K W, Mossine V, Ortwerth B J. The relative ability of glucose and ascorbate to glycate and crosslink lens proteins in vitro.  Exp Eye Res. 1998;  67 95-104
• 25 Webster J, Wilke M, Stahl P, Kientsch-Engel R, Munch G. Maillard reaction products in food as pro-inflammatory and pro-arteriosclerotic factors of degenerative diseases.  Z Gerontol Geriatr. 2005;  38 347-353
• 26 Laakso M, Kuusisto J. Epidemiological evidence for the association of hyperglycaemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.  Ann Med. 1996;  28 415-418
• 27 Cohen J D. Overview of physiology, vascular biology, and mechanisms of hypertension.  J Manag Care Pharm. 2007;  13 S6-S8
• 28 Calcutt N A, Cooper M E, Kern T S, Schmidt A M. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials.  Nat Rev Drug Discov. 2009;  8 417-430
• 29 Brownlee M. Advanced protein glycosylation in diabetes and aging.  Annu Rev Med. 1995;  46 223-234
• 30 Lee H S, Koo Y C, Suh H J, Kim K Y, Lee K W. Preventive effects of chebulic acid isolated from Termialia chebula on advanced glycation endproduct-induced endothelial cell dysfunction.  J Ethnopharmacol. 2010;  131 567-574
• 31 Juang L J, Sheu S J, Li T C. Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis.  J Sep Sci. 2004;  27 718-724
• 32 Basta G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.  Atherosclerosis. 2008;  196 9-21
• 33 Jay D, Hitomi H, Griendling K K. Oxidative stress and diabetic cardiovascular complications.  Free Radic Biol Med. 2006;  40 183-192